Published April 2, 2025 | Version Version 1
Thesis Open

Behçet's disease - contemporary etiopathogenetic explanations, current diagnosis and treatment possibilities

Authors/Creators

  • 1. Independent Researcher; presented at Bukovinian State Medical University (BIMCO 2025)

Description

This review aims to provide a comprehensive overview of Behçet’s disease (BD), a chronic, relapsing, multisystem inflammatory disorder with unclear etiology. It synthesizes recent findings on genetic predispositions, environmental triggers (e.g., Streptococcus sanguinis), immune dysregulation (Th17 cells, Tregs), and novel therapeutic strategies including biologics targeting interleukins. BD is characterized by mucocutaneous lesions, ocular involvement, vasculitis, and other systemic manifestations. This thesis emphasizes integrating contemporary research into clinical practice to improve diagnosis and management.

Files

PAMBODAN_SASNO_ASNIMD,_M1962,_Behcets_disease-contemporary_etiopathogenetic_explanations,_current_diag.pdf

Files (1.2 MB)

Additional details

Identifiers

URL
https://drive.google.com/drive/folders/1MwPa1J8uqhuTN2OvX_PS38lToLVuOeqe?usp=drive_link

Related works

Is referenced by
Conference paper: https://drive.google.com/drive/folders/1MwPa1J8uqhuTN2OvX_PS38lToLVuOeqe?usp=drive_link (URL)

Dates

Issued
2025-04-02
BIMCO 2025 Conference, Bukovinian State Medical University

References

  • Abdolmohammadi R, Bonyadi M. Polymorphisms of Promoter Region of TNF-α Gene in Iranian Azeri Turkish Patients with Behçet's Disease. J Korean Med Sci. 2017;32:33. doi: 10.3346/JKMS.2017.32.1.33
  • Accorinti M, Pesci FR, Pirraglia MP, Abicca I, Pivetti-Pezzi P. Ocular Behçet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis. Ocul Immunol Inflamm. 2017;25:29–36. doi: 10.3109/09273948.2015.1094095
  • Akiyama M, Kaneko Y, Takeuchi T. Effectiveness of tocilizumab in Behcet's disease: A systematic literature review. Semin Arthritis Rheum. 2020;50:797–804. doi: 10.1016/J.SEMARTHRIT.2020.05.017
  • Aldinucci A, Bonechi E, Biagioli T, Repice AM, D'Elios MM, Emmi L, Emmi G, Silvestri E, Barilaro A, Ballerini C. CSF/serum matrix metallopeptidase-9 ratio discriminates neuro Behçet from multiple sclerosis. Ann Clin Transl Neurol. 2018;5:493–498. doi: 10.1002/ACN3.538
  • Alibaz-Oner F, Mumcu G, Kubilay Z, Ozen G, Celik G, Karadeniz A, Can M, Oner SY, Inanc N, Atagunduz P, Ergun T, Direskeneli H. Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers. Clin Rheumatol. 2014;33:1773–1776. doi: 10.1007/S10067-014-2585-3